trial · primary record
acyclovir-penciclovir cream
Herpes Simplex Oral
| Phase | Phase 2 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 58 |
| Primary completion | 2025-11-30 |
| Primary endpoint | Proportion of Subjects Using Acyclovir-penciclovir Cream Versus Those Using the Comparator, Who do Not Progress to Stage 3 (Vesicle) of a Herpes Labialis Outbreak Following UV Radiation Exposure |
| Registry ID | NCT06558838 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:33:08.075Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06558838
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.